Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has received an average recommendation of “Hold” from the four research firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year target price […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned a consensus rating of “Hold” from the four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.62 and traded as low as $0.55. Atara Biotherapeutics shares last traded at $0.57, with a volume of 1,833,007 shares trading hands. Analyst Upgrades […]
Equities research analysts at StockNews.com began coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Several other research firms have also commented on ATRA. HC Wainwright lowered shares of Atara Biotherapeutics from a […]
StockNews.com initiated coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. ATRA has been the subject of a number of other reports. Mizuho cut shares of Atara Biotherapeutics from a buy rating to a neutral […]